#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Peter Smith Email
VP, Program And Alliance Management . MEI Pharma
How to contact Peter Smith
Join and see Peter's contact info for free!Current Roles
Employees:
151Revenue:
$33.3MAbout
MEI Pharma (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. Our lead drug candidate is Pracinostat, a potential best-in-class, oral HDAC inhibitor that has been granted Breakthrough Therapy Designation from the FDA in combination with azacitidine for the treatment of patients with newly diagnosed AML who are ?75 years of age or unfit for intensive chemotherapy. Our pipeline of drug candidates also includes ME-401 (formerly PWT143), a next-generation oral PI3K delta inhibitor, and ME-344, a novel mitochondrial inhibitor. For more, please go to www.meipharma.com.MEI Pharma Address
11455 El Camino Realnull, null